The growing market for injectable peptides includes many schedule 4 drugs that are not yet approved for use in Australia but can be prescribed by a doctor CJC 1295 & Ipamorelin Injection Pen Australia Subcutaneous Inject+ A health warning about unregulated peptides has been issued by Australia's drug regulator but doctors say more action is needed. Reporting by national health equity reporters Caitlyn Gribbin and Rachel Carbonell, ABC Safety advisory Understanding your responsibilities when importing, compounding and supplying unapproved peptide products We are concerned about the rise in the import, supply, compounding and advertising of unapproved peptide products Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia Therapeutic Innovation & Regulatory Science Springer Nature Link Understanding Australia's Regulatory Framework Arena